The number of people with susceptibility test result for rifampicin in Singapore

Singapore: The number of people with susceptibility test result for rifampicin was 98.69 in 2021. ▬ Flat

Latest (2021)
98.69
Change on year
up 0.5%
World rank
35th
of 146 countries
All-time high
98.69
in 2021
All-time low
96.96
in 2017
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Singapore, 2017–2021

0204060801002017201920212017: 972018: 98.22019: 97.22020: 98.22021: 98.7

Source: World Health Organization, Global Health Observatory.

Analysis

Singapore recorded 98.69 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.

That represents a change of up 0.5% on the previous year and up 1.8% over five years.

That places Singapore 35th out of 146 countries with data for 2021, putting it in the top quarter.

The number of people with susceptibility test result for rifampicin in Singapore, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. in Singapore, 2017 to 2021.
Year Value Change
2017 96.96
2018 98.16 +1.2%
2019 97.18 -1.0%
2020 98.16 +1.0%
2021 98.69 +0.5%

Singapore compared with similar countries

  • Singapore's 98.69 is above the median for high income countries, which is 92.6, 1.1× the median. (56 countries reporting)
  • Singapore's 98.69 is above the median for East Asia & Pacific, which is 96.47, 1.0× the median. (28 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 97.43 96.96 98.16 3
2020s 98.42 98.16 98.69 2

Countries ranked near Singapore

  1. 32 Kazakhstan 99.88 compare
  2. 33 Georgia 99.79 compare
  3. 34 Macau, China 98.97 compare
  4. 36 Norway 98.57 compare
  5. 37 Slovenia 98.31 compare
  6. 38 Bosnia and Herzegovina 97.7 compare

See the full ranking of 148 places →

More health data for Singapore

All data for Singapore →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Singapore?
The number of people with susceptibility test result for rifampicin in Singapore was 98.69 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Singapore?
The highest recorded value was 98.69 in 2021.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Singapore?
The lowest recorded value was 96.96 in 2017.
How does Singapore rank for the number of people with susceptibility test result for rifampicin?
Singapore ranks 35th out of 146 countries with data for 2021.
Where does this Singapore data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Singapore. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 16 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/singapore/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/singapore/">The number of people with susceptibility test result for rifampicin in Singapore</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed